BioPharma Credit Supports Amicas Acquisition of 10 Gene Therapies

Amicus Therapeutics signed an agreement to obtain worldwide development and commercial rights for 10 gene therapy programs. BioPharma Credit provided a $150 million term loan to support the purchase.

BioPharma Provides New $150MM Facility for Novocure

Novocure entered into a $150 million term loan agreement with BioPharma Credit, an investment fund managed by Pharmakon Advisors.

BioPharma Provides $500MM Term Loan for TESARO

TESARO, an oncology-focused biopharmaceutical company, entered into a definitive term loan agreement with Biopharma Credit and BioPharma Credit Investments IV, investment funds managed by Pharmakon Advisors.